TY  - JOUR
TI  - Validity and reliability of the Turkish version of the
central sensitization inventory
AB  - Objectives: The aim of this study was to translate the Central Sensitization Inventory (CSI) into the Turkish language, to perform a psychometric
validation, and to investigate its reliability in patients with chronic spinal pain with an organic origin, patients with fibromyalgia, and pain-free
control individuals.
Patients and methods: Between April 2016 and February 2017, the translation of the original English version of the CSI into Turkish was
performed using the forward-backward translation method. A total of 100 fibromyalgia patients (6 males, 94 females; mean age: 45.0±8.4
years; range, 25 to 60 years), 100 patients with chronic spinal pain with an identified organic origin (CSPO), (10 males, 90 females; mean age:
43.8±9.7 years; range, 21 to 60 years), and 100 healthy controls (8 males, 92 females; mean age: 35.8±10.1 years; range, 25 to 55 years) were
included in the study. Demographic characteristics were collected. Test-retest reliability was determined by re-administering the CSI-Turkish
(CSI-Turk) two weeks after the first application.
Results: The internal consistency (Cronbach's alpha) was found to be 0.92 and the intraclass correlation coefficient was 0.93. Patients with
fibromyalgia, a very common central sensitivity syndrome (CSS), had the highest mean CSI-Turk scores, and healthy controls had the lowest. Using
the recommended cut-off score of 40 resulted in 87% sensitivity and 90% specificity in distinguishing between fibromyalgia and control individuals.
Conclusion: This study suggests that the CSI-Turk can be effectively used as a screening tool to elucidate CS-related symptomology among patients
with chronic pain with a high internal consistency, test-retest reliability, sensitivity, and specificity.
AU  - Birtane, Murat
AU  - EKUKLU, GALIP
AU  - KILINCER, Cumhur
AU  - Caliyurt, Okan
AU  - Tastekin, Nurettin
AU  - İş, Enes Efe
AU  - Ketenci, Ayşegül
AU  - Neblett, Randy
AU  - DUZCE KELES, ELA
DO  - 10.46497/ArchRheumatol.2021.8665
PY  - 2021
JO  - Archives of Rheumatology
VL  - 36
IS  - 4
SN  - 2148-5046
SP  - 518
EP  - 526
DB  - TRDizin
UR  - http://search/yayin/detay/511481
ER  -